Allgens(SH:688613) Zheng Quan Zhi Xing·2025-07-02 16:14Core Viewpoint - The company is holding a temporary shareholders' meeting on July 11, 2025, to discuss adjustments to fundraising projects and their implementation details [1][2][10]. Group 1: Meeting Procedures - The meeting will start at 14:30 and will require attendees to sign in 30 minutes prior [2][5]. - Only shareholders, directors, supervisors, senior management, and authorized personnel are allowed to attend [1]. - Voting will be conducted both on-site and online, with specific time slots for each method [3][6]. Group 2: Fundraising and Investment Projects - The company raised approximately RMB 547.67 million through an initial public offering, with a net amount of RMB 500.82 million after expenses [10]. - The company plans to adjust the implementation subject and location of certain fundraising projects, specifically canceling the involvement of its subsidiary in Jiaxing [12][14]. - New projects will include "Mineralized Collagen/Sulfate/Phosphate Calcium Self-setting Bone Cement," which aims to address the increasing incidence of bone defects [15][16]. Group 3: Project Adjustments - The "Aojing Health Technology Industrial Park Construction Project" will now be managed by Beijing Aojing Medical Device Co., Ltd. instead of Jiaxing Aojing [12][14]. - The project will cease funding for the "Artificial Skin" sub-project due to unsatisfactory progress and will focus on the new sub-project [14][16]. - The adjustments are intended to enhance project management and ensure effective use of raised funds [12][16].